Ovarian Reserve in Women With Cystic Fibrosis and the Correlation With Demographic and Clinical Parameters

Last updated: August 27, 2021
Sponsor: Hadassah Medical Organization
Overall Status: Active - Recruiting

Phase

N/A

Condition

Infertility

Cystic Fibrosis

Lung Disease

Treatment

N/A

Clinical Study ID

NCT05029817
HMO-0298-21
  • Ages 18-45
  • Female

Study Summary

The main objective of this study is to assess the ovarian reserve of CF patients via measurement of AMH and AFC. Secondly, we aim to correlate between the ovarian reserve and demographic and clinical characteristics of these patients.

Outcomes measured will be levels of AMH and AFC, as compared to standard means in the general population. There is no need for a control group in this study since the standardized means of AMH and AFC in the general population are a more accurate comparable measure, which is based on data collected from large-scale populations, and thus accounts for confounding age factor in a more complete manner than can be obtained via a control group (Almog et al., 2011, La Marca et al., 2012, Penzias et al., 2020).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female patients diagnosed with CF according to genetic testing.
  • Age 18-45 years old.
  • Routinely attended the CF Center at Hadassah Medical Center.

Exclusion

Exclusion Criteria:

  • Refusal to participate in the study.
  • Age under 18 or above 45.
  • Use of hormonal contraceptives (for the purpose of AFC).

Study Design

Total Participants: 30
Study Start date:
July 15, 2021
Estimated Completion Date:
December 31, 2021

Connect with a study center

  • Hadassah Medical Organization, Jerusalem, Israel

    Jerusalem,
    Israel

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.